Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

18.94
Delayed Data
As of Dec 02
 +0.39 / +2.10%
Today’s Change
12.25
Today|||52-Week Range
27.02
+4.47%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close18.55
Today’s open18.47
Day’s range18.44 - 19.20
Volume1,320,311
Average volume (3 months)1,570,441
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+51.47%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-0.30-0.98%
ALDRAlder Biopharmaceuti...+0.20+0.88%
EGRXEagle Pharmaceutical...+0.85+1.14%
OPHTOphthotech Corp+2.21+6.87%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts


Search for Jobs